CERo Therapeutics announces 1-for-20 reverse stock split effective June 13, 2025

CERO THERAPEUTICS HOLDINGS, INC.

Outstanding shares reduced from ~10,321,839 to ~516,092; par value $0.0001 unchanged.
Split-adjusted trading begins June 13 under symbol CERO; new CUSIP 71902K402.
No fractional shares; fractional holders receive rounding up to next whole share.
Proportional adjustments made to outstanding options, warrants, and preferred stock.
Stockholders approved a 1-for-2 to 1-for-25 range at May 29, 2025 annual meeting; board set 1-for-20.

item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.